VistaGen Therapeutics Inc

NASDAQ:VTGN   3:59:29 PM EDT
0.76
-0.01 (-0.96%)
Earnings Announcements

Vistagen Therapeutics Reports Fiscal 2021 Q2 Financial Results

Published: 11/12/2020 22:32 GMT
VistaGen Therapeutics Inc (VTGN) - Vistagen Therapeutics Reports Fiscal 2021 Second Quarter Financial Results and Provides Highlights on Its Cns Pipeline and Business Progress.
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.